Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT00200538
PHASE2
Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
Sponsor: Nantes University Hospital
View on ClinicalTrials.gov
Summary
The purpose of this trial is to assess the efficacy and tolerability of memantine (anti-excitotoxic, neuroprotective treatment currently used in Alzheimer's disease \[AD\]) in frontotemporal dementia patients after a one-year treatment.
Official title: Double-blind, Parallel Group, Placebo-controlled Trial of the Efficacy and Tolerability of Memantine (20 mg) in Frontotemporal Dementia (FTD) Patients
Key Details
Gender
All
Age Range
45 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
52
Start Date
2005-09
Completion Date
Not specified
Last Updated
2026-09-14
Healthy Volunteers
No
Conditions
Interventions
DRUG
memantine
Locations (1)
Martine Vercelletto
Nantes, France